- Investor's Business Daily•last year
The European Union's medical advisory committee endorsed several key drugs from leading stocks Friday, making EU approval likely for some potential blockbusters: • The Committee for Medicinal Products ...
- Investor's Business Daily•2 years ago
Top-rated specialty drugmaker Horizon Pharma beat first-quarter sales estimates and settled a patent suit, but its stock fell 6% to 27.62 on Friday. Horizon's (HZNP) earnings excluding one-time items rose ...
- Zacks•2 years ago
Horizon Pharma (HZNP) is scheduled to report first-quarter 2015 results before the opening bell on May 8.
Requested symbol wasn't found
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
As of 3:00PM EST. Market open.
|Day's range||0.00 - 0.00|
Trade prices are not sourced from all markets
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|